Cross Country Healthcare Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Cross Country Healthcare stock has a consensus rating of "Hold" and an average price target of $12.44. The average 1-year stock price forecast is 5.72% lower than the current stock price, while the lowest is $10 (-24.21%) and the highest is $13.25 (+0.42%).

Price Target: $12.44 (-5.72%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$10	$12.44	$13.25	$13.25
Change	-24.21%	-5.72%	+0.42%	+0.42%

Analyst Ratings

The average analyst rating for Cross Country Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	0	0	0	2	2	0
Buy	0	1	1	1	2	1
Hold	7	7	8	6	5	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	8	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tobey Sommer Truist Financial	Truist Financial	Hold Reiterates $10 → $13	Hold	Reiterates	$10 → $13	+0.42%	May 11, 2026
Bill Sutherland Benchmark Co.	Benchmark Co.	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	May 8, 2026
Constantine Davides Citizens JMP	Citizens JMP	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	May 7, 2026
Michael Piccolo Wedbush	Wedbush	Hold Maintains $13	Hold	Maintains	$13	+0.42%	May 7, 2026
Trevor Romeo William Blair	William Blair	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

982.47M

from 1.05B

-6.81%

from 1.05B

Revenue Next Year

1.02B

from 982.47M

4.22%

from 982.47M

EPS This Year

0.09

from 0.02

325.00%

from 0.02

EPS Next Year

0.28

from 0.09

231.09%

from 0.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.68B	2.80B	2.02B	1.34B	1.05B	982.47M
Revenue Growth	100.46%	67.20%	-27.95%	-33.46%	-21.56%	-6.81%
Gross Profit	375.00M	624.46M	450.41M	274.25M	213.57M	197.29M
Gross Margin	22.37%	22.28%	22.30%	20.41%	20.26%	20.08%
Operating Income	145.10M	278.06M	116.04M	-725.00K	2.54M	2.30M
Net Income	132.00M	185.98M	72.63M	-14.56M	-94.85M	53.87K
EPS	-	-	-	-	0.02	0.09
EPS Growth	-	-	-	-	-95.65%	325.00%
Forward PE	11.67	8.24	17.20	37.47	125.97	155.24
Free Cash Flow	-124.74M	87.15M	236.67M	124.95M	42.77M	18.39M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.0B
Avg	982.5M
Low	968.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-3.1%
Avg	-6.8%
Low	-8.2%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.09
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	325.0%
Low	-